MBA
LAW
LANGUAGES

COUGAR BIOTECHNOLOGY CGRB (NASDAQ)

$ 37.67

19:09

Change: unch (unch%)
Volume: 264,915

Avg. Volume:	98146
P/E Ratio:	0
EPS (Annual):	-0.74
Profit Margin:
Dividend & Yield(Annual):	0%
Shares Outstanding:	20,530
Institutional Shareholders:	69.96%

Last:	37.67
Change:	unch (unch%)
Prev. Close:	37.67
Open:	38.15
Day's Range:	37.52 - 40.00
52wk Range:	17.00 - 40.00
Market Value:	760,350
Beta:

12-month EPS Change:	0.00%
Total Return Last 12 Months:	+63.78%
Total Return Last 3 Years:	+87.70%
Total Return Last 5 Years:	+115.26%
5-Year Revenue Growth Rate:	0.00%
5-Year Dividend Growth Rate:	0.00%
5-Year EPS Growth Rate:	0.00%

Headlines on CGRB

Alert me

Russell 2000 adds 53 health care companies

(NEW YORK)More than 50 companies in the health care sector were added to the Russell 2000 in this year's reconstitution of the small stock index, while 30 companies in the sector were re...READ MORE

Jun 30, 2008 2:16PM

Keywords: ACCL, ACUR, ADLR, AFAM, ATEC, RDEA, ATRI, CALP, CSCX, CSY, CLDA, CBRX, CGRB, CYTX, DEPO, DYAX, EXAC, HGR, IDRA, ISPH, L

Sector Wrap: Celgene, Genentech in ASCO spotlight

(NEW YORK)Analysts said Celgene Corp. and Genentech Inc. are their top picks heading into the 44th annual American Society of Clinical Oncology meeting, or ASCO, taking place May 30 to June ...READ MORE

May 16, 2008 4:04PM

Keywords: CELG, DNA, IMCL, AMGN, ARIA, CGRB, EXEL, GENZ, IMGN, OSIP, PARD